broken trust


a repostnativelandnow
James Warren – James Warren is/was a journalist who worked for the Chicago Tribune, writes columns for the New York Times and Business Week and is a political analyst for MSNBC.

First posted on Jun 7 2010, 12:21 PM ET |

Mistreatment of Indians is America’s Original Sin, and the narrative is consistent.
They lose their land, get portrayed as caricatures of social maladies, and are ripped off by the likes of Jack Abramoff.
So it’s no surprise that a tale with a very different ending, namely the righting of a horrible wrong affecting 500,000 Native Americans, proceeds with virtually no notice.Indeed, you’d think that even Tea Party diehards should rally to this cause, given their anti-government and pro-property rights passion. They might even want to pay homage to the intrepid female accountant-turned-banker, who inspired one of the most fiercely litigated disputes against the federal government in history. But they likely won’t. Who will? Not even many Indians believe that belated fairness is now on the way, given more than a century of government abuse and deceit whose undisputed facts strain credulity.
The facts are these: Following the House’s approval, the Senate is considering whether to approve a $3.4 billion settlement of a 15-year-old lawsuit, alleging the government illegally withheld more than $150 billion from Indians whose lands were taken in the 1880s to lease to oil, timber, minerals and other companies for a fee. Back then, the government started breaking up reservations, accumulating over 100 million acres, giving individual Indians 80 to 160 acres each, and taking legal title to properties placed in one of two trusts.
The Indians were given beneficial ownership but the government managed the land, believing Indians couldn’t handle their affairs. With leases for oil wells in Oklahoma, resorts in Palm Springs, and rights-of-ways for roads in Scottsdale, Arizona, some descendants of original owners receive six- and even seven-figure sums annually. But the prototypical beneficiary, now poised to share in the settlement, is a poor Dakotan who struggles to afford propane to heat his quarters and has been receiving as little as $20 a year.   More than $400 million a year is collected from Indian lands and paid into U.S. Treasury account 14X6039.The story turns on theft and incompetence by the Interior and Treasury Departments, with culprits including Interior’s Bureau of Indian Affairs (BIA) and the same Minerals Management Service now at the center of the BP oil spill fiasco.

Over the past 100 years, government record systems lost track of more than 40 million acres and who owns them. The records simply vanished. Meanwhile, documents were lost in fires and floods, buried in salt mines or found in an Albuquerque storage facility covered by rat feces and a deadly Hantavirus. Government officials exploited computer systems with no audit trails to turn Indian proceeds into slush funds but maintain plausible deniability.The lack of accountability is confirmed in the government’s own reports and testimony dating to the early 20th century. Conclusions of “fraud,” “corruption,” “institutional incompetence,” “deficiencies in accounting,” “the accounts lack credibility,” “multifaceted monster,” “organizational nightmare,” “dismal history of inaction,” “criminal negligence,” and “sorry history of department mismanagement,” are found regularly between 1915 and the present.  Congress ordered an accounting in 1994 but interior secretaries in both the Clinton and George W. Bush administrations were held in civil contempt for not forking over records. District Judge Royce Lamberth, a Texas Republican nominated by President Reagan who oversaw the case for a decade, called the whole matter “government irresponsibility in its purest form.”I sat in Lamberth’s courtroom in 1999 when Interior Secretary Bruce Babbitt both lost his cool and conceded that the government couldn’t provide accurate cash balances of most accounts and that “the fiduciary obligation of the United States is not being fulfilled.” But the dispute would not end, as the Clinton and Bush administrations fought unceasing adverse rulings in a case inspiring 3,600 separate court filings and 80 published decisions. No single case, including the antitrust action against Microsoft, has been as heavily litigated and defended by the government, say lawyers.The government’s chief nemesis has been Elouise Cobell, a member of the Blackfeet Nation in Montana, the accountant-turned-banker who in 1987 started Blackfeet National Bank, the first national bank on a reservation. With a very small team of attorneys led by a Washington banking specialist, Dennis Gingold, her suit has inspired 3,600 court filings and 80 published decisions. Not even the antirust action against Microsoft was as heavily litigated by the government.The historic resistance melded with an unsympathetic appeals court often overruling the dispute’s two trial judges. It ordered removal of Lamberth, now the district court’s chief judge, due to harsh language toward the government. Last year, it threw out a ruling by District Judge James Robertson, Lamberth’s successor, that the Indians were owed $476 million, a pittance compared to the reduced, $48 billion they were seeking by then. Presidential candidates Barack Obama and John McCain both urged settlement during the 2008 campaign.

A resolute Judge Robertson then hauled Interior Secretary Ken Salazar and plaintiffs into his chambers last year. He made clear to one and all that, in light of the latest appeals court ruling, both sides had the choice between spending maybe another 10 years in court or trying to finally settle. The initial atmosphere was not necessarily conducive to harmony. Career government employees in the Interior, Justice and Treasury departments felt burned after years of being belittled by both the plaintiffs and Judge Lamberth. Meanwhile, the plaintiffs had minimal trust in the government. But political appointees in the Obama administration, including Salazar and Attorney General Eric Holder, took their cue from President Obama’s own support of a settlement. Dozens of meetings ensued, with the many prickly issues including how far back in time one would go to try to determine who should benefit.

Ultimately, Judge Robertson prodded what, given all the legal setbacks, is an impressive $3.4 billion deal announced in December. Ironically, before the recent congressional recess, the House approved the deal and Robertson announced his retirement, meaning District Judge Thomas Hogan becomes the third, and hopefully final, arbiter in the case. He would oversee a so-called “fairness hearing” in which objections can be raised.

There is inherent complexity in wrapping up. If the Senate approves, there will be a media campaign throughout Indian Country, including direct mail, newspaper and broadcast public service advertisements. Garden City Group of Melville, New York, which handled the major class action against Enron, will be claims administrator. It will get computer lists from the Interior Department, with the account information of perhaps 500,000 Indians and then doublecheck names and addresses. How good are the records? Nobody is really sure.

The $3.4 billion will be placed in a still-to-be-selected bank and $1.4 billion will go to individuals, mostly in the form of checks ranging from $500 to $1,500. A small group, such as members of the Osage tribe who benefit from huge Oklahoma oil revenues, will get far more, based on a formula incorporating their 10 highest years of income between 1985 and 2009. As important, $2 billion will be used to buy trust land from Indian owners at fair market prices, with the government finally returning the land to tribes. Nobody can be forced to sell. As for the winning lawyers, their take is capped at $100 million, actually low by class-action standards, though Republican Sen. John Barrasso of Wyoming, an orthopedic surgeon, has groused about the fees.

The fairness hearing will be interesting since many Indians have a hard time believing they’re not still being shafted. “This proposed settlement fixes nothing, the U.S. won by legal weaseling,” writes a member of the Upper Midwest’s Prairie Band Potawatomi tribe on a message board. He’s not alone. Like a family victimized by homicide, Indians may never experience enough healing to truly recover. But, finally, as hard as it is for them to believe, there really may be some justice.

 There were many responses to this article written by Mr. Warren; but the one response I had to add is…below ~ Nativegrl77
Thoms M. Wabnum
My article was reference in yours.
This is the complete article as posted in other websites. Thank you for posting it.
First, I would like to thank Ms. Cobell for the strength and courage to fight the U.S. on our behalf for the past 13 years.
This proposed settlement fixes nothing, the U.S. won by legal weaseling.
This lawsuit maybe settled but the mismanagement and corruption continues. The centuries old broken government trust is still broken. The IIM accounts are still not reconciled. to death, this settlement adds another one.
If all Individual Indian lands are bought off and transferred over to tribal trust property, the same historical broken trust is there not to protect it or improve it. The same slumlord mentality, scalawag management and Judge Roy Bean justice prevails all because we are Native Americans.
The U.S. did send a message to Indians in Cobell. They will extend Indian claims in courts indefinitely until the claimants die, exhaust funding and cave into perennial stonewalling.
The historical damage done to Native people, their land and money goes unchecked and without consequence. Not one employee faced criminal charges, was removed or fired for deliberately wasting billions in taxpayer’s dollars in cover up schemes. The U.S. won’t even apologize for inflicting termination and terrorism on the people they are legally bound to protect. At least, Canada and Australia apologized to the Natives of their countries.
After the starting Judge and court appointed investigators proved that DOI/BIA/OST wasted billions of dollars trying to fix the broken trust they too were removed from the case. The U.S. were found in contempt of court for lying to a federal judge, filing false reform reports, destroying records and for 13 years of federal failure. Honest American federal employees who reported such fraud, waste and abuse termed “whistleblowers” were also squeezed out of service and replaced with puppets.
“On June 20, 1867, Congress established the Indian Peace Commission to negotiate peace with Plains Indian tribes who were warring with the United States. The official report of the Commission to the President of the United States, dated January 7, 1868, describe detailed histories of the causes of the Indian Wars including: numerous social and legal injustices to Indians, repeated violations of numerous Treaties, acts of corruption by many of the local agents, and culpability of Congress itself for failing to fulfill certain legal obligations. The report asserts that the Indian Wars were completely preventable had the United States government and its representatives acted with legal and moral honesty in dealing with the Indians.”
In short, this 1867 Commission also “recommended that the intercourse laws with Indian Tribes be thoroughly revised.” This sounds like trust reform to me.
Second, “But it is insisted that the present Indian service is corrupt, and this change should be made to get rid of the dishonest. That there are many bad men connected with the service cannot be denied. The records are abundant to show that gents have pocketed the funds appropriated by the government and driven the Indians to starvation.” And still today, the U.S. Courts, it’s investigators, GAO and OIG all exposed corrupt employees in Indian Affairs.
Third, “That Congress pass an act fixing a day (not later than the 1st of February, 1869) when the offices of all superintendents, agents, and special agents shall be vacated. Such persons as have proved themselves competent and faithful may be reappointed. Those who have proved unfit will find themselves removed without an opportunity to divert attention from their own unworthiness by provisions of party zeal.”
This 1867 Commission told the President how to get rid of corrupt employees and even today it has not been done. Why?
Fourth, “We, therefore, recommend that Indian affairs be committed to an independent bureau or department. Whether the head of the department should be made a member of the President’s cabinet is a matter for the discretion of Congress and yourself, and may be as well settled without any suggestions from us.” This 1867 Commission told the President that there should be a Department of Indian Affairs separate from the Department of Interior.
Two other recommendations by this 1867 Commission talked about State encroachment on tribal sovereignty and shady traders.”
In 1973, Senator James Abourezk introduced Senate Joint Resolution No. 133 to establish a Federal commission to review all aspects of policy, law, and administration relating to affairs of the United States with American Indian tribes and people. The Senate and the House of Representatives both adopted S.J. Res. 133 and on January 2, 1975, the Resolution was signed into law by the President, thus establishing the American Indian Policy Review Commission [Public Law 93-580]. There are other Commissions in 1928, 1934 and 1992.
But after 141 years and Commissions, this proposed settlement still does not protect our land, money, fleecing or our natural resources and culture but promotes tribal sovereignty erosion and U.S. failure to enforce treaty rights and their federal trust responsibilities according to their own U.S. Constitution and Congressional obligations.
The U.S. can send a man to the Moon and maybe Mars, travel to the bottom of the deepest Ocean, fight wars on opposite side of the world, clone animals but cannot fix the broken trust problem with Indian services.
If the U.S. initially worked with earnest and full trust with Native Nations using their own money plus the promised federal appropriations, there would not be a financial burden on either party, national dishonesty or worldwide disgrace of American ideals.
It has been settled for me to forget all that happened within DOI and accept the $1,500.00 minus reserves/taxes (unknown amount) and attorney fee’s (unknown amount) as if nothing happened.
Thomas M. Wabnum
Prairie Band Potawatomi
Former Tribal Councilperson
Viet Nam Veteran
IIM Accountholder
BIA/OST retired

Metformin Hydrochloride ~ Marksans Pharma Nationwide Recall


Marksans Pharma Limited Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)

“Label, Time-Cap Labs, Inc. Metformin Hydrochloride 500mg tablets”

Marksans Pharma Limited, India is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004, to the consumer level. FDA analysis has found the product to contain N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit (ADI) of 96ng/day.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant found in water and foods, including meats, dairy products and vegetables. Marksans Pharma Limited has not received any reports of adverse events related to this recall to date.

Metformin Hydrochloride Extended-Release Tablets, USP 500mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus and is packaged in 100 count bottles with NDC code 49483-623-01. The affected Metformin Hydrochloride Extended-Release Tablets, USP 500mg, are white to off white, capsule shaped, biconvex tablets, debossed with ‘101’ on one side and plain on the other side.

Product name: Metformin Hydrochloride Extended Release Tablets USP, 500 mg

Lot #: XP9004

Expiry Date (MM/YYYY): 12/2020

The product can be identified by lot # XP9004 and expiration date 12/2020. Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004 was distributed by Time-Cap Labs, Inc. (located at 7 Michael Avenue, Farmingdale, New York 11735) nationwide in the USA to wholesalers who further distributed to pharmacies.

Marksans Pharma Limited is notifying its distributors and customers by issuing notification letter and press release and is arranging for return/replacement etc. of recalled product lot. Distributors/retailers that have Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004 which is being recalled should return to place of purchase.

Consumers with questions regarding this recall and return can contact Ms. Irene McGregor (Vice President, Regulatory Affairs) of Time-Cap Labs, Inc., located at 7 Michael Avenue, Farmingdale, New York 11735, by phone number 631-753-9090; ext. 160, [Monday to Friday 8am-5pm EST] or e-mail address imcgregor@timecaplabs.com.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Metformin Hydrochloride – Teva Pharmaceuticals Nationwide Recall


Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA)

Teva Pharmaceuticals USA, Inc. is voluntarily recalling fourteen (14) lots of Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, 100 and 1000 count bottles, in the United States to the consumer-level due to the detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit (ADI).

NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

Metformin Hydrochloride is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. The lots being recalled are packaged under the Actavis Pharma, Inc. label and are contained in the table below. They were distributed nationwide in the USA as retail bottles of 100 tablets and 1000 tablets to Teva’s direct customers between January 8, 2019 and May 27, 2020.

The affected Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, being recalled are described as:

  • Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, white to off-white capsule shaped tablets, debossed with an Andrx logo with “571”on one side and “500” on the opposite side.
  • Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, light yellow capsule shaped tablets, debossed with an Andrx logo with “577” on one side and “750” on the opposite side.
NDC Product Description Lot Number Expiration
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1329548A 06/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1338302M 10/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1348968M 10/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1348969M 11/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1348970M 10/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1376339M 09/2021
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1323460M 06/2020
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1330919M 06/2020
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1338300A 10/2020
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1341135M 12/2020
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1391828M 11/2021
62037-577-01 Metformin Hydrochloride Extended-Release Tablets, USP 750 mg 100 Count 1333338M 08/2020
62037-577-01 Metformin Hydrochloride Extended-Release Tablets, USP 750 mg 100 Count 1333339A 08/2020
62037-577-10 Metformin Hydrochloride Extended-Release Tablets, USP 750 mg 1000 Count 1354471A 02/2021

“Label, Actavis Metformin Hydrochloride Extended-Release Tablets, 500 mg, 100 tablets”

Teva is notifying its distributors and customers affected by this recall via FedEx overnight mailing. Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. According to the US Food & Drug Administration, It could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professionals. Please visit the agency’s website for more information at https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-metformin.

“Label, Actavis Metformin Hydrochloride Extended-Release Tablets, 750 mg, 100 tablets”

Customers and patients with medical-related questions, who wish to report an adverse event, or quality issues about the Teva products being recalled should contact Teva Medical Information by phone at: 888-838-2872, option 3, then, option 4. Live calls are received Monday-Friday, 9:00 am to 5:00 pm Eastern Time with voicemail available 24 hours/day, 7 days/week or by email at druginfo@tevapharm.com.

“Label, Actavis Metformin Hydrochloride Extended-Release Tablets, 500 mg, 1000 tablets”

Patients wishing to return product may contact Teva’s product recall processor to obtain instructions and a return kit for returning their medication:

“Label, Actavis Metformin Hydrochloride Extended-Release Tablets, 750 mg, 1000 tablets”

  • Contact Inmar at 1-855-532-1850 (Hours of Operation: 9 am to 5 pm Eastern Time, Monday – Friday) or email Inmar at: tevarecalls@inmar.com.
  • Inmar will provide the materials needed to return their medication and instructions for reimbursement.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.